DMAC

DiaMedica Therapeutics Inc.

Contracts

Total Value

Stock Metrics

18.2%

Short % Float

27.4d to cover · Moderate squeeze

38.6%

Inst % Float

10 holders · 2026-06-30

Blackrock Inc.

Top Holder

4.2% of float

28.6M sh

Public Float

40/100

Dilution Score

Medium

22 mo

Cash Runway

Verified regulatory filings & proprietary analysis.

Dilution Risk

40/100

MEDIUM

Inst: 38.63% · Top: Blackrock Inc.

Biotech Analytics

Biotech / Pharma

28.3

Squeeze risk: MODERATEBiotech Grade: F

Insider Buying0

Publications100

Dilution Risk40

Clinical Trials38

Short Interest50